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The first experiments that seemed to indicate the presence
of a substance with significant biological effects in the prostate
gland of humans were made by Battez and Boulet in 1913,who
observed that extract of fresh human prostate tissue caused
a strong depressor action on the blood pressure of dogs. In
1930, Kurzrok and Lieb ~ made the interesting observation
that uteri from patients who had completed sucessful pregnancies
responded with relaxation upon addition of seminal fluid, but
uteri from women who had a history of complete or long standing
53
sterility were stimulated. Shortly after this, von Euler
and Goldblatt independently reported the smooth muscle
stimulating and vaso depressor properties of human semen.
Due to the occurence of this biologically active compound in
extracts of the prostate and vesicular glands, it was called
prostaglandin.
The observation in a variety of smooth muscle tissues
of antagonistic as well as agonistic actions of prostaglandin
Ei and E^ (PGEj , PGE2) on muscle contraction have stimulated
more detailed investigations. Much interest has recently been
focused on a role for prostaglandin in the modulation of
sympathetic neuromuscular transmission.
Electrical stimulation of sympathetic nerve fibers
depolarize the cell membrane ; causing release of stored
- 2 -
norepinephrine. This norepinephrine crosses the neuromuscular
junction and causes the depolarization and appropriate responses
in the effector cells. It has been proposed by Hedqvist and
others that endogenous prostaglandins of the E series modulate
nervous transmission by a feedback mechanism, thus modifying
the effector responses to nerve impulses in two ways:
prostaglandin appears to inhibit the pre- junctional release
of norepinephrine, and at the same time potentiate the effect
of any norepinephrine present post- junctional ly-
- 3 -
Pre-jnnoticnal Effects
Prostaglandin E, and prostaglandin E, have been shov;n
to decrease release of norepinephrine following electrical
1 2
stimulation of the splenic nerve in cats. ' In a further
study dealing with responses to graded doses of pr es-caglandin
E? in the cat spleen, prostaglandin E_ was found ;. : markedly
and reversibly depress the outflow of norepinephrine in
response to splenic nerve stimulation."5 (Mechanic! responses
of the spleen were similarly affected by low doses of prosta
glandin E.) Furthermore, this inhibition of norepinephrine
release was found to progressively increase with the concen^
tration of prostaglandin E. In a spleen loaded with labeled
norepinephrine, almost all of the radioactive material released
4
by nerve stimulation consists of unchanged norepinephrine.
Prostaglandin E caused a closely parallel reduction of the
outflow of radioactively and f luorometrically determined
norepinephrine, thus indicating that altered metabolic degrada-
3
tion of norepinephrine is of minor importance.
There is further evidence that the action of prostaglandin
is directly on the release of norepinephrine from the sympathetic
nerve terminal. Prostaglandin E does not inhibit the conduc-
5
tion of impulses in sympathetic nerves. It is therefore
unlikely that the reduced outflow of norepinephrine in the
- 4 -
presence of prostaglandin is due to decreased conduction
of impulses. The arterio-venous difference in tritium
3
labeled norepinephrine in the cat spleen was not appre
ciably changed in the presence of prostaglandin E_ in con
centrations known to severely effect the outflow of
norepinephrine in response to nerve stimulation. Thus it
is unlikely that prostaglandin E reduces the outflow of
norepinephrine by facilitating re-uptake of norepinephrine
released from the nerve terminals.
Prostaglandin E, and prostaglandin E inhibit the re
lease of norepinephrine during electrical stimulation of the
fi 7
guinea pig vas deferens. ' The contractile response to
electrical nerve stimulation is likewise inhibited in the
presence of low doses of the prostaglandins of the E series.
Prostaglandin E, and prostaglandin E? progressively
and reversibly inhibited the outflow of norepinephrine
following sympathetic nerve stimulation in the perfused
rabbit heart, as well as the inotropic and chrontropic
responses. Following infusion of exogenous norepinephrine,
however, the chronotropic and inotropic responses were only
slightly andunpredictably effected by prostaglandin E, or
prostaglandin E- within the same dose range, ' ' ' thus
indicating the importance of prostaglandin's pre-junctional
5action. The only difference between prostaglandin E, and
prostaglandin E? in the action on the rabbit heart seemed
to be that prostaglandin Ej more markedly reduced the inotropic
response to nerve stimulation, whereas prostaglandin E-, more
markedly reduced the chronotropic response.
There is some evidence that prostaglandin may act pre- junctional ly
31
on cholinergical ly innervated tissues as well. The mechanism
is not yet fully understood, although it is suggested that prostaglandin
acts to block the calcium influx at the axonal membrane induced
37 33
by depolarization.
Post- junctional Effect
The prostaglandins of the E series may modulate sympathetic
neurotransmission by potentiating the post- junctional effect
of norepinephrine. The administration of norepinephrine directly
stimulates the post- junctional effector cells. Thus, following
the administration of norepinephrine, the post- junctional effect
of prostaglandin can be investigated, completely excluding any
pre-junctional action. ' ': , .
In the cat spleen, the mechanical response to nerve stimulation
is modified by prostaglandin Ej in a manner somewhat different
3
from its effect directly on norepinephrine release. Whereas the
vascular pressor and capsular contractile responses were
reduced in the presence of low doses of prostaglandin Eo , with
- 6 -
higher doses the pressor response returned to near normal,
although the capsular response was further depressed. A
similar pattern was seen when the nerve stimulation was
replaced by administration of norepinephrine, the pressor
response being moderately reduced by low doses of prosta
glandin E but markedly increased by high doses. This
observation is in agreement with data from isolated vascular
12
"
. .
strips. The results with prostaglandin E, are qualitative-
2 3
ly similar. '
The contractile response to electrical stimulation in the
guinea pig vas deferens ' and guinea pig seminal vesicle
is inhibited in the presence of low doses of prostaglandin E,
or prostaglandin E, but potentiated by high doses. On the
other hand, contractile responses to norepinephrine are
potentiated by low as well as high doses of prostaglandin E,
or prostaglandin E. In addition, when electrical stimulation
of the seminal vesicle was replaced by administration of
norepinephrine, contractions were increased by prostaglandin
E, or prostaglandin E? in doses known to reduce the response
14
to nerve stimulation. Thus the interaction of the pre
junctional and post-junctional actions of prostaglandin in
electrically stimulated tissue may yield biphasic results in
the presence of varying prostaglandin concentrations. After
- 7 -
norepinephrine administration on the other hand, only the
post-junctional potentiating effect of prostaglandin is
present.
Site of Origin
Endogenous prostaglandin E and F~ O^ are released
from the dog and cat spleen during electrical stimulation
of the splenic nerve or perfusion with norepinephrine or
epinephrine. ' It is unlikely that the source of these
prostaglandins is the nerve fibers. Antagonists for alpha
receptors prevent splenic contraction and also prevent
release of prostaglandins in response to nerve stimulation.
In addition, the release of prostaglandins from isolated
spleens which had been denervated 8 and 9 days earlier was
studied. These spleens contract in response to perfused
epinephrine, accompanied by an output of prostaglandin.
Histological examination of the stimulated tissues shows
that they contain substantial nerve trunks in various stages
of degeneration. Electrical stimulation of the degenerate
nerve produces a slight rise in resistance to perfusion but
no resultant output of prostaglandin. Increasing the
perfusion pressure into the spleen, whether by infusion of
vasopressin increasing flow into the spleen, or impeding
- 8 -
outflow from the spleen, is not accompanied by prosta
glandin release. It is suggested that the prostaglandin
originates in the capsular smooth muscles. Infusion of
prostaglandin E alone into the spleen does not produce
any splenic contraction. Epinephrine similarly applied
contracts the spleen and releases prostaglandin.
Further evidence of the regulatory role of endogenous
prostaglandin was obtained from studies of the rabbit heart.
Prostaglandin E, and prostaglandin E are released from
the rabbit heart in response to sympathetic nerve stimula
tion, in quantities capable of inhibiting the neuronal
release of norepinephrine. The release of prostaglandin of
the E series from the heart during non-stimulated conditions
is much smaller, perfusate from the stimulated heart being
significantly more capable of reducing heart rate and outflow
of labeled norepinephrine than perfusate from the non-stimulated
spontaneously beating heart. Thin layer chromatography of the
perfusate confirms the presence of both prostaglandin E, and
^ , t t, 17,18,19prostaglandin E_.
The outflow of prostaglandin E in these rabbit heart
preparations is not affected by the alpha blocking drug
_:heno:ybenzamine, or the beta blocking drug propranolol, the
latter in doses sufficient to completely block the mechanical
response to infusion of norepinephrine. In experiments in
which the adrenergic nerves were almost completely destroyed,
20
the outflow of prostaglandin E is not significantly altered.
Thus, prostaglandin in the rabbit heart does not appear to be
derived from the adrenergic nerves, or via receptors which
are influenced by alpha or beta blocking agents. Mechanical
response of the effector cell is not a prerequisite for
prostaglandin release. Increased formation and release of
prostaglandin E compounds in response to sympathetic nerve
21 22
stimulation has also been reported in rat and dog adipose
23
tissue, and in the dog kidney.
Inhibitors of Prostaglandin Synthesis
Experiments using inhibitors of the synthesis of prosta
glandins provide further evidence for the role of endogenous
prostaglandin in modulating sympathetic nervous activity.
Indomethacin, an inhibitor of prostaglandin synthesis, ' '
decreases the level of prostaglandins and increases the
25
response to epinephrine infusion in dog spleens. Indomethacin is
associated with increased release of labeled norepinephrine in
the electrically stimulated guinea pig vas deferens and in
creased sympathetic responses in the electrically stimulated cat
spleen. The chemically unrelated inhibitor of prostaglandin
- 10 -
2 7 2 8
synthesis, 5,8,11,14 eicosatetraynoic acid, ' has been
shown to increase the release of norepinephrine from stimu-
2 9 28
lated guinea pig vas deferens, rabbit heart, and cat
, 30
spleen.
Experimental uptake and field stimulation-induced
release of Norepinephrine
Adrenergic nerves take up and accumulate administered
H-norepinephrine in vivo and i_n vitro. ' 'An isolated
iris preparation maintained in oxygenated physiologic buffer
at 37C will retain its metabolic and electrical properties
for several hours.
'
Field stimulation of nervous
tissue will cause depolarization of the nerve cell membrane
* * -x-x. 39,40,41,42,43,44,37,45,46and release of transmitters.
Adrenergic nerves in the rat iris actively take up
3
H-norepinephrine and incorporate it into the amine storage
35 ...
granules to a very high extent. Rat lrides incubated in a
3
buffer containing H-norepinephrine release this labeled neuro
transmitter from the amine storage granules when subjected to
37 45
field stimulation. ' More than 95% of the tritium taken
up and accumulated in similarly incubated rat irides is
3 34
unchanged H-norepinephrine. During field stimulation of
35
heart and brain slices, and in studies with mouse vas
- 11 -
deferens, 70% of the tritium efflux is H-norepinephrine.
The spontaneous efflux of tritium is initially fairly rapid
. . 37
in these lrides but declines to reach a fairly stable level
after 20 minutes. Under the influence of field stimulation
(12 milliamps, 2 milliseconds, 10 per second) there is a
marked increase in the tritium outflow. Such stimulation, con
tinued for 60 minutes, lowers the total tritium content of
the iris to 42% of that in the unstimulated control. The
decrease in tritium in the stimulated iris is equal to the
net stimulation induced efflux in the superfusing medium.
Some areas of the adrenergic nerves when examined in the
47 37
fluorescent microscope
' show a moderate decrease of nor
epinephrine fluorescence activity with a smooth appearance of
the nerve terminal and less prominent varicosities than did
the unstimulated control.
3
When lrides previously incubated with H-norepinephrine
are perfused in a buffer containing reserpine phosphate, a
known inhibitor of neuronal norepinephrine uptake the results
37
are even more pronounced. There is a considerable spontaneous
efflux of tritium which decreases gradually. The effect of
stimulation is maintained only for the first 15 minutes and
then rapidly diminishes. For the last 15 minutes of the 6 0
minute stimulation the norepinephrine outflow from the
- 12 -
unstimulated iris exceeds that of the stimulated iris. In
the stimulated iris almost no fluorescent activity in the
adrenergic nerve is found, in contrast to the unstimulated
control iris which has weakly fluorescent varicose nerve
terminals. The tritium content of the stimulated iris
decreases to 37% of the content of the unstimulated control.
Thus, with the reuptake of liberated, norepinephrine blocked
by the reserpine, the adrenergic neurons 'undergo an even
more pronounced depletion of norepinephrine under the in
fluence of field stimulation. In the case of rats pretreated
with reserpine and nialamide before dissection and incubation
3
in H-norepinephrine, there is no difference in tritium efflux
or fluorescent histological appearance between the stimulated
and control iris. Thus, if the capacity of the tissue to
3
actively transport H-norepinephrine into its adrenergic
neuronal storage granules is pharmacologically blocked, field
stimulation will be unable to provoke a release of the tritium
labeled neurotransmitter.
42
In a subsequent study in which a more accurate enzymatic
determination of norepinephrine levels was included the above
conclusions are confirmed. Field stimulation of irides from
untreated rats lowers their norepinephrine content to 6 0% of
that of unstimulated control. Fluorescent histochemical
- 13 -
changes in microscopic examination of the adrenergic nerves
parallel the results of the enzymatic assay for norepinephrine.
It is thus apparent that field stimulation induces the
3
release of H-norepinephrine from the neuronal amine storage
granules. This process is augmented in the presence of a
3
drug which blocks reuptake of liberated H-norepinephrine
by the nerve terminals, and eliminated completely when the
. . . 3
tissue is originally incubated in the H-norepinephrine in
the presence of a drug which blocks its uptake into the
neuronal storage granules. The decrease of fluorescent
intensity in the adrenergic nerves provides further evidence
that it is neuronal norepinephrine which is released during
field stimulation; in addition when no increase in tritium
efflux is obtained no change in the microscopic appearance of
the nerve is seen.
There thus appears to be good evidence that neuronal
H-norepinephrine is released from storage granules in the
adrenergic nerves in field stimulated tissue, and that most
of the stimulus induced tritium efflux in such cases repre-
3
sents and consists of unchanged H-norepinephrine .
Purpose
It is becoming increasingly clear that endogenous prosta
glandins play an important modulating role in sympathetic
- 14 -
neurotransmission in an ever widening circle of tissues
and organs. Prostaglandins have been shown to inhibit
pre-junctional neuronal norepinephrine release, and
potentiate the effect of norepinephrine on the post
junctional effector cell.
Under the influence of electrical field stimulation,
neuronal 3H-norepinephrine is released from neuronal amine storage
granules in previously incubated adrenergic tissues. Further
more, most of the stimulus-induced tritium efflux in such
3
cases represents and consists of this H-norepinephrine.
The purpose of the present investigation was to demon
strate the pre-junctional inhibitory effect of prostaglandin
E, on adrenergic norepinephrine release in the rabbit iris.
MATERIALS AND METHODS
General
Male albino rabbits weighing 2-3 kg were sacrificed by
ether inhalation, and their eyes were rapidly enucleated. A
freshly made modified Krebs-Ringer-bicarbonate buffer was
available which had the following composition: 118 mM NaCl;
4.8 mM KCl;0.33mM CaCl2; 1 . 2 mM KH2P04; 1 . 2 mM MgS04;
- 15 -
25 mM NaHC0o; 0 . 1 mM ascorbic acid; and 10 mM dextrose, at pH 7.4.
The buffer was constantly aerated by bubbling compressed air through
it. Prostaglandin El (Upjohn Company, Michigan) was diluted in
10% absolute ethanol , 90% de-ionized water. It was kept frozen
in 0.04 ml aliquots containing 0.002 mg PGE^ until immediately
prior to use. The prostaglandin E-i aliquots were then diluted with
warmed (37 C.) aerated buffer to form a final PGEj concentration
of 10 ng/ml , 20 ng/ml , or 60 ng/ml in the solution perfusing the
iris chamber.
Isolated Iris-Sclera Preparation
Following enucleation the eyes were placed in warmed aerated
buffer solution. The posterior two- thirds of the globe was removed.
The cornea was removed following trephining, by circumferential
excision just on the corneal side of the limbus. The lens was
gently brushed away, along with the vitreous humor, from the ciliary
body, and then the remaining scleral portions were cleansed of
excess uveal tissue without damage to the base of the iris. The
scleral ring, with the iris attached, was mounted between two lucite
o-rings by perforating and connecting needles.
Norepinephrine Uptake Phase
The iris- sclera preparation mounted in the lucite o-rings
was incubated at 37 C. for 45 minutes in 5 ml of the aerated buffer
3
solution which contained d,l- H-norepinephrine (9.4 C/mMole)
(New England Nuclear Corporation, Boston, Massachusetts). The
norepinephrine concentration was 8.5 x 10 M. In the experiments
where indicated, 3 x 10" M cocaine sulfate was present.
- 16 -
Perfusion Chamber
A lucite perfusing chamber was used in the subsequent
stages of the experiment. Externally its dimensions were
3.1 centimeters by 4.4 centimeters by 3.8 centimeters. The
inner chamber, constructed to hold the iris-sclera o-ring
sandwich was cylindrical with diameter 1.1 centimeters and
height 1.3 centimeters, internal volume 1.23 cubic millimeters.
Two circular platinum electrodes were present on either end
of the cylinder. Aerated buffer at 37 C could be perfused
through this inner chamber at a variable rate. In addition,
fluid at 37C could be perfused through the outer chamber
to maintain and stabilize the temperature.
Norepinephrine Release Phase
Following the uptake phase the iris preparation was
rinsed in 8 0 ml of warm, aerated buffer, and then transferred
to the perfusing chamber. Buffer was perfused through the
chamber at a rate of 2.0 ml per minute. The effluent was
collected from the outflow of the chamber in one minute
samples by a fraction collector. Where indicated, PGE, was
added to the perfusing media to give a final concentration cf
10 or 60 ng/ml.
- 17 -
0.2 ml of each collected 1 min sample was transferred
to a liquid scintillation counting vial, and 10 ml of
Aquasol (New England Nuclear Corporation) was added. The
vials were counted for 10 min each in the Nuclear Chicago
Corporation Mark II Liquid Scintillation System.
Field stimulation was accomplished with the two circu
lar platinum electrodes inside the inner perfusion chamber
on either side of the mounted iris. The stimulation was
provided by a Grass SD5 stimulator at 10 pulses per second,
each pulse being 18 volts and 3.2 milliseconds duration.
The pulses were monophasic, and the polarity was reversed
each minute. Stimulation was continued in this manner for
10 minutes.
RESULTS
When an iris, which has been previously incubated in
3
the presence of H-norepinephrine, is washed m the perfusion
chamber with buffer, a continuously decreasing tritium efflux
occurs (Figure 1) . If electrical field stimulation is applied,
an additional stimulus-induced tritium efflux occurs (Figure 2) ,
creating an upward sloping portion of the curve representing a
cuantitative increase in the tritium efflux.
- 18 -
In other experiments, the iris was incubated in the
3
H-norepinephrine in the presence of cocaine. Active up
take of the labeled norepinephrine into the neuronal amine
storage granules is presumably blocked pharmacologically.
These irides were subsequently placed in the perfusion
chamber and electrically field stimulated. No
stimulus-induced tritium efflux occurred; the curve was
continuously decreasing (Figure 3) .
When prostaglandin E-. was present in the perfusing
medium at a final concentration of 10 ng/ml, no stimulus-
induced tritium efflux occurred; the efflux continuously
decreased (Figure 4) . Thus, stimulus- induced release of
norepinephrine from the neuronal amine storage granules does
not occur in similar quantities in the presence of this con
centration of prostaglandin E, .
Effects of prostaglandin E-, in concentrations of 20
ng/ml were equivocal. With prostaglandin E, in the per
fusing medium at a final concentration 60 ng/ml, a stimulus-
induced tritium efflux occured (Figure 5) . Thus the
inhibitory effect of prostaglandin E, on the neuronal re
lease of labeled norepinephrine appears to be inversely
related to its concentration, within the range studied.
- 19 -
DISCUSSION
We have developed a method for effectively electrically
field-stimulating an isolated rabbit iris. This isolated
_
o 3
ix^is, incubated in 5 ml of the 8.5 x 10 M H-norepinephrine
solution, is able to incorporate some of this labeled
norepinephrine into its neuronal amine storage granules.
With the onset of field stimulation, an increase in
tritium efflux from the perfused iris occurs, representing
release of %-norepinephrine from the neuronal amine
storage granules. Cocaine present in the incubating
solution ( 3 x 10 M. ) blocks only the active uptake
3 50
of H-norepinephrine into these granules , and
electrical field-stimulation of irides so incubated
does not result in an increase in tritium efflux.
Thus, the field- stimulation- induced peak of tritium
3
efflux represents release of H-norepinephrine from the
amine storage granules on the nerve terminals.
Hedqvist and others have proposed that prostaglandins
modify sympathetic neurotransmission by a pre-junctional
inhibition of norepinephrine release, and by a post- junctional
alteration of the effector response to norepinephrine
released. In the presence of 10 ng/ml prostaglandin Ej
in the solution perfusing the iris, no field-stimulation
- 20 -
induced peak of tritium efflux occured. Thus, we have
shown that prostaglandin E-. at this concentration
inhibits the pre-junctional release of norepinephrine
in the rabbit iris. This represents a confirmation of
the pre-junctional part of Hedqvist's hypothesis for the
rabbit iris. This is the first demonstration of the
validity of the first part of Hedqvist's hypothesis
for any ocular tissue in any species, and raises the
possibility that the sympathetic control of the iris may
be modified by endogenous prostaglandins. The significance
of the loss of efficacy of prostaglandin Ej_ at
a concentration of 60 ng/ml in the perfusing medium
is not yet clear.
Figure 1
Tritium counts per minute versus time in efflux
from the unstimulated iris. Each point is the mean -
S.E.M. of collected one minute samples of the effluent
from 3 irides.
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Figure 2
Tritium counts per minute versus time in
efflux from the electrically field-stimulated iris.
Each point is the mean -t S.E.M. of collected one minute
samples of the effluent from 6 irides.
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Figure 3
Tritium counts per minute versus time in efflux
from the electrically field- stimulated iris which has
3been incubated in H-norepinephrine in the presence of
3 x 10" M cocaine. Each point is the mean t S.E.M.
of collected one minute samples of the effluent from
4 irides.
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Figure 4
Tritium counts per minute versus time in afflux f * >i
the electrically fi eld- st imulated iris with 10 urVml
PGEj present in the perfusing solution. Ea< h point
is the mean t S.E.M. of collected one minute
samples of the effluent from 4 irides.
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Figure 5
Tritium counts per minute versus time in efflux tr >m
the electrically f ield- stinulated iris with 60 ng/ml
PGEi present in the perfusing solution. Each point
is the mean i S.E.M. of collected one minute samples
of the effluent from 4 irides.
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